Antibiotic Treatment Improves the Efficacy of Oxaliplatin-Based Therapy as First-Line Chemotherapy for Patients with Advanced Gastric Cancer: A Retrospective Study
Hiroo Imai, Ken Saijo, Keigo Komine, Reio Ueta, Ryunosuke Numakura, Shonosuke Wakayama, Sho Umegaki, Sakura Hiraide, Yoshufumi Kawamura, Yuki Kasahara, Kota Ohuchi, Masahiro Takahashi, Shin Takahashi, Hidekazu Shirota, Masanobu Takahashi, Chikashi Ishioka Department of Medical Oncology, Tohoku Unive...
Principais autores: | Imai H, Saijo K, Komine K, Ueta R, Numakura R, Wakayama S, Umegaki S, Hiraide S, Kawamura Y, Kasahara Y, Ohuchi K, Takahashi M, Takahashi S, Shirota H, Ishioka C |
---|---|
Formato: | Artigo |
Idioma: | English |
Publicado em: |
Dove Medical Press
2022-03-01
|
coleção: | Cancer Management and Research |
Assuntos: | |
Acesso em linha: | https://www.dovepress.com/antibiotic-treatment-improves-the-efficacy-of-oxaliplatin-based-therap-peer-reviewed-fulltext-article-CMAR |
Registros relacionados
-
Evaluation of Outcome and Tolerability of Combination Chemotherapy with Capecitabine and Oxaliplatin as First Line Therapy in Advanced Gastric Cancer
por: Mohammad Ali Mashhadi, et al.
Publicado em: (2016-10-01) -
Phase II study of adjuvant chemotherapy with S1 plus oxaliplatin for Chinese patients with gastric cancer
por: Guoxiu Wang, et al.
Publicado em: (2018-05-01) -
Comparison of the Efficacy of S-1 Plus Oxaliplatin or Capecitabine Plus Oxaliplatin for Six and Eight Chemotherapy Cycles as Adjuvant Chemotherapy in Patients With Stage II-III Gastric Cancer After D2 Resection
por: Yuanyuan Yu, et al.
Publicado em: (2021-05-01) -
Comparison of PSOX (paclitaxel, oxaliplatin, S-1) and SOX (oxaliplatin, S-1) as postoperative adjuvant chemotherapy for stage II-III gastric cancer
por: Fei-Yu Wang, et al.
Publicado em: (2025-03-01) -
A clinical prognostic scoring system for resectable gastric cancer to predict survival and benefit from paclitaxel- or oxaliplatin-based adjuvant chemotherapy
por: Qian J, et al.
Publicado em: (2016-02-01)